ABT Financial Facts
Cost of products sold: 2.29BOperating Earnings: 897M
See Full Income Statement
Other accrued liabilities: 2.72B
Total Liabilities and Shareholders' Investment: 39.5B
See Full Balance Sheet
Abbott Labs (ABT) Earnings
|
Expand Research on ABT
| Next EPS Date | 7/18/24 *Est. | EPS Growth Rate | -4.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +2.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | +1.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/19/23 | Q123 | $1.03 | $0.99 | +$0.04 | $9.75B | $9.66B |  |
 | | Details | |
1/29/15  |
 |
Q414 | $0.71 | $0.69 | +$0.02 | $5.36B | $5.48B | = | | | Details |
| 7/20/23 | Q223 | $1.08 | $1.05 | +$0.03 | $10B | $9.69B | |
| | Details | |
| 1/24/18 | |
Q417 | $0.74 | $0.73 | +$0.01 | $7.6B | $7.39B | = | | | Details |
| 10/18/23 | Q323 | $1.14 | $1.10 | +$0.04 | $10.1B | $9.82B | |
| | Details | |
| 10/20/21 | |
Q321 | $1.40 | $0.93 | +$0.47 | $10.9B | $9.44B | = | | | Details |
| 7/18/18 | |
Q418 | $0.73 | $0.71 | +$0.02 | $7.8B | $7.76B | |
| | Details |
| 7/17/19 | |
Q219 | $0.82 | $0.80 | +$0.02 | $8B | $8B | |
| | Details |
